908 Devices Inc. (MASS)
NASDAQ:MASS
Want to see MASS full AI Analyst Report?
MASS Stock Chart & Stats
$6.20
-$0.07(-3.29%)
At close: 4:00 PM EST
$6.20
-$0.07(-3.29%)
Day’s Range― - ―
52-Week Range$4.20 - $9.34
Previous CloseN/A
Volume74.64K
Average Volume (3M)265.23K
Market Cap
$275.49M
Enterprise Value$209.60M
Total Cash (Recent Filing)$112.97M
Total Debt (Recent Filing)$4.63M
Price to Earnings (P/E)9.8
Beta1.05
Next Earnings
May 12, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding37,379,950
10 Day Avg. Volume238,402
30 Day Avg. Volume265,230
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.32
Price to Sales (P/S)3.38
P/FCF Ratio-7.72
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue3.73
Enterprise Value/Gross Profit7.37
Enterprise Value/Ebitda-6.88
Forecast
1Y Price Target
$8.00Price Target Upside29.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.42
Revenue Forecast (FY)$65.33M
Bulls Say, Bears Say
Bulls Say
Balance Sheet And ValuationDivestiture of non-core desktop assets paired with a debt-free balance sheet and ample cash reduces financial risk and may enable focus on core growth while leaving room for valuation re-rating versus peers.
Profitability ImprovementPositive adjusted EBITDA, improving gross margins, and narrowing operating losses point to meaningful progress toward profitability and potential for future free cash flow generation.
Revenue GrowthAnalyst highlights guidance signaling continued revenue growth driven by stronger sales across state and local, federal, and international channels, supporting expectations for higher top-line momentum.
Bears Say
Customer Demand VisibilityInsufficient clarity on customer demand trends in key public sector and international markets raises the risk that current sales momentum could slow unexpectedly.
Guidance Assumptions ClarityAnalyst requests more detail on the assumptions behind guidance, creating uncertainty about the credibility and sustainability of the company’s revenue and margin outlook.
New Product Adoption RiskUncertainty around adoption rates for recently launched products and partnerships could delay expected revenue contributions and weaken near-term growth prospects.
908 Devices News
MASS FAQ
What was 908 Devices Inc.’s price range in the past 12 months?
908 Devices Inc. lowest stock price was $4.20 and its highest was $9.34 in the past 12 months.
What is 908 Devices Inc.’s market cap?
908 Devices Inc.’s market cap is $275.49M.
When is 908 Devices Inc.’s upcoming earnings report date?
908 Devices Inc.’s upcoming earnings report date is May 12, 2026 which is in 26 days.
How were 908 Devices Inc.’s earnings last quarter?
908 Devices Inc. released its earnings results on Mar 03, 2026. The company reported $0.011 earnings per share for the quarter, beating the consensus estimate of -$0.074 by $0.085.
Is 908 Devices Inc. overvalued?
According to Wall Street analysts 908 Devices Inc.’s price is currently Undervalued.
Does 908 Devices Inc. pay dividends?
908 Devices Inc. does not currently pay dividends.
What is 908 Devices Inc.’s EPS estimate?
908 Devices Inc.’s EPS estimate is -0.14.
How many shares outstanding does 908 Devices Inc. have?
908 Devices Inc. has 37,379,950 shares outstanding.
What happened to 908 Devices Inc.’s price movement after its last earnings report?
908 Devices Inc. reported an EPS of $0.011 in its last earnings report, beating expectations of -$0.074. Following the earnings report the stock price went down -4.387%.
Which hedge fund is a major shareholder of 908 Devices Inc.?
Currently, no hedge funds are holding shares in MASS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
908 Devices Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.00 (29.03% Upside)
$8.00 (29.03% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 54.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.5%
Last 30 Days ▲ 6.4%
Last 30 Days ▲ 6.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
65.61%
12-Months-Change
Fundamentals
Return on Equity
13.25%
Trailing 12-Months
Asset Growth
19.18%
Trailing 12-Months
Company Description
908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized clear operational progress: accelerating product adoption (Explorer, Viper), meaningful revenue growth (Q4 +21%, FY +18%), improved margins, a positive Q4 adjusted EBITDA, and a strong cash position ($113M). At the same time, material non‑cash charges influenced full-year reported losses, adjusted EBITDA remains negative for the year, some production and contracting timing risks persist, and planned investments could moderate near‑term margin improvement. Management provided constructive 2026 guidance (15%–20% revenue growth; margin expansion; halving adjusted EBITDA loss), signaling confidence in execution while acknowledging remaining risks.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$8.00
▲(29.03% Upside)
Technical Analysis
Senseonics Holdings
―
Quanterix
―
Nano-X Imaging
―
TriSalus Life Sciences
―
Cytek Biosciences
―
Ownership Overview
Currently, No data available
---